Needham & Company LLC Lowers TScan Therapeutics (NASDAQ:TCRX) Price Target to $9.00
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) had its target price lowered by research analysts at Needham & Company LLC from $11.00 to $9.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 332.69% from […]
TScan Therapeutics (NASDAQ:TCRX – Get Free Report) had its target price lowered by research analysts at Needham & Company LLC from $11.00 to $9.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 332.69% from […]
